REG - Fevertree Drinks PLC - Results of General Meeting

Fevertree DrinksAnnouncement

Today 13:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251017:nRSQ8849Da&default-theme=true

RNS Number : 8849D  Fevertree Drinks PLC  17 October 2025

17 October 2025

 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Results of General Meeting

Fever-Tree, the world's leading supplier of premium carbonated mixers, is
pleased to announce that at the General Meeting of the Company held earlier
today, the special resolution proposed in the Notice of General Meeting was
duly passed on a poll.

 

Ends

 

For further information:

 

Investor queries

Steve Nightingale, Director of Investor Relations I
steve.nightingale@fever-tree.com I +44 7951 849564

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I +44 (0)20 7597 5970

Corporate Broker - Jefferies International Limited

Ed Matthews I +44 (0)20 7029 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan +44 (0)7826 534 233

 

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for
alcoholic spirits by retail sales value, with distribution to over 90
countries worldwide. Based in the UK, the brand was launched in 2005 to
provide high quality mixers which could cater to the growing demand for
premium spirits, in particular gin, but also increasingly for vodka, rum and
whisky. The Company now sells a range of carbonated mixers to hotels,
restaurants, bars and cafes ("On Trade") as well as selected retail outlets
("Off Trade").

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ROMMZMMGZNRGKZM



            Copyright 2019 Regulatory News Service, all rights reserved